findmyKOL
Clinical trialNCT04490031RecruitingPhase 4Interventional

Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)

SponsorUniversiti Kebangsaan Malaysia Medical CentreEnrollment140Ketamine Adverse Reaction
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Malaysia
  • University Kebangsaan Malaysia Medical Center

    Bandar Tun Razak, Kuala Lumpur, Malaysia

    Azlanudin Azman, MDIan Chik, MDMuhammad Hafiz Ismail, MBBSNorma Mohamad, MDZamri Zuhdi, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Mar 2020
Primary completion
31 Dec 2020
Completion
30 Apr 2021
Last update posted
28 Jul 2020
Registered enrollment
140
Registry id
NCT04490031
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.